ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
SK Life Science has completed a $7 million expansion of its pilot plant and kilo lab in Daejeon, South Korea. The expanded facility includes eight new batch reactors ranging in size from 500 to 1,000 L, the firm says. SK also added a continuous-reaction module for low-temperature and catalytic reactions. Separately, the company says its commercial facility has been successfully inspected by Japanese authorities. The visit included a preapproval inspection of a continuous process for making a late-stage precursor to an active pharmaceutical ingredient.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X